ReviewCancers2021

Current Systemic Treatment Options in Metastatic Urothelial Carcinoma after Progression on Checkpoint Inhibition Therapy-A Systemic Review Combined with Single-Group Meta-Analysis of Three Studies Testing Enfortumab Vedotin.

Susanne Deininger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.